Trial Profile
A Phase 1B/2A study to demonstrate the safety and efficacy of CXA-10 in the treatment of Sickle Cell Crisis and Sickle Cell Disease
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 20 Nov 2015
Price :
$35
*